Psychiatry

Tardive Dyskinesia

Advertisment
Central Dopamine Blockade in the Pathophysiology of Tardive Dyskinesia
Tardive Dyskinesia

Central Dopamine Blockade in the Pathophysiology of Tardive Dyskinesia

expert roundtables
By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH
Practice Guidelines on Tardive Dyskinesia
Tardive Dyskinesia

Practice Guidelines on Tardive Dyskinesia

expert roundtables
By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH
Dopamine Receptor–Blocking Agent Exposure in the Pathophysiology of Tardive Dyskinesia
Tardive Dyskinesia

Dopamine Receptor–Blocking Agent Exposure in the Pathophysiology of Tardive Dyskinesia

clinical topic updates
By Andrew J. Cutler, MD
Antipsychotic Switching Strategies in Tardive Dyskinesia
Tardive Dyskinesia

Antipsychotic Switching Strategies in Tardive Dyskinesia

clinical topic updates
By Andrew J. Cutler, MD
Clinical Trials, Long-term Follow-up, and Experience With VMAT2 Inhibitors
Tardive Dyskinesia

Clinical Trials, Long-term Follow-up, and Experience With VMAT2 Inhibitors

clinical topic updates
By Andrew J. Cutler, MD
Load More   

Experts in Tardive Dyskinesia

+0

Meet the Experts   

Advertisment